The Daily Papule

JAAD IntObservational study

Global patterns of melanoma, burden attributable to ultraviolet radiation exposure, and projections to 2050 across 185 countries

A population-based study with global modeling.

Oh J, Kim S, Hwang SH, Son Y, Lee J, Kim J, López Sánchez GF, Pizzol D, Hwang J, Yon DK

JAAD InternationalIn the feed 26 Jul 2026, published online 12 Jun 2026, issue 2026 Aug, added to PubMed 26 Jul 2026

Topics: Skin cancer & tumorsMelanoma & molesPhotodermatology & sun protection

Abstract

BACKGROUNDUltraviolet radiation (UVR) is a well-established modifiable risk factor for malignant melanoma, yet global estimates of its attributable burden remain limited.

OBJECTIVESTo provide up-to-date global estimates of the melanoma burden and quantify the contribution of UVR.

METHODSWe examined melanoma burden in 2022, the most recent ten-year trends, and projected estimates for 2050 by sex, age, and Human Development Index (HDI) using GLOBOCAN data, CI5plus, and the World Health Organization Mortality Databases. As a secondary analysis, population attributable fractions for UVR exposure were calculated for 2022 and 2050, using sex-specific reference populations with low exposure, incorporating demographic changes in the projections.

RESULTSIn 2022, an estimated 330,000 new melanoma cases were reported, with ∼88% attributable to UVR using the fifth percentile reference. Incidence, overall and UVR-attributable, was highest in high-HDI countries, especially Oceania and Northern Europe, while mortality-to-incidence ratios were highest in low-HDI settings. By 2050, UVR-attributable cases are projected to rise, with the steepest growth in low- and medium-HDI settings.

LIMITATIONSModels are subject to uncertainties in cancer registration, especially in low-HDI regions.

CONCLUSIONMelanoma remains largely UVR-attributable, with substantial regional disparities. The projected increase in UVR-attributable melanoma burden in lower-HDI settings underscores the urgent need for region-specific prevention strategies.

Abstract from PubMed

PMID 42502459 · DOI 10.1016/j.jdin.2026.05.026

Comments